NORTHERN TRUST CORP - CHECKMATE PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 37 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2021$987,000
+11.4%
81,359
+34.0%
0.00%–
Q4 2020$886,000
+38.2%
60,738
+9.2%
0.00%–
Q3 2020$641,000–55,639–0.00%–
 Download
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders